Peripheral T-cell lymphomas: Initial features, natural history, and prognostic factors in a series of 174 patients diagnosed according to the R.E.A.L. Classification

Annals of Oncology

Volumn 9, Issue 8, 1998, Pages 849-855

  Lopez Guillermo A ^a   Cid, J ^a   Salar, A ^b   Lopez A ^c   Montalban C ^d   Castrillo, J M ^e   Gonzalez M ^f   Ribera, J M ^g   Brunet, S ^h   Garcia Conde J ⁱ   De Fernandez Sevilla A ^b   Bosch, F ^a   Montserrat, E ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Institut Catalá d'Oncologia

^c Residencia 'Vall d'Hebrón' ^*

^d Hospital 'Romón y Cajal'

^e Fund 'Jiménez Diaz'   (Spain)

^f HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

^h HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

ⁱ HOSPITAL CLÍNICO UNIVERSITARIO   (Spain)

Author keywords

Peripheral T cell lymphomas; Prognosis

Indexed keywords

DOXORUBICIN;

ADOLESCENT; ADULT; AGED; ANGIOIMMUNOBLASTIC LYMPHADENOPATHY; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER RECURRENCE; FEMALE; HISTOLOGY; HUMAN; HUMAN TISSUE; INTESTINE LYMPHOMA; LARGE CELL LYMPHOMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; T CELL LYMPHOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; FEMALE; HUMANS; LYMPHOMA, T-CELL, PERIPHERAL; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RISK FACTORS; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL;

EID: 7344221466     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008418727472     Document Type: Article

References (38)

1. Lennert K, Feller AC. Histopathology of non-Hodgkin's lymphomas (based on the Updated Kiel Classification). Berlin: Springer-Verlag 1992.
2. Harris NL, Jaffe ES, Stein H et al. A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 1994; 84: 1361-92.
3. Greer JP, York JC, Cousar JB et al. Peripheral T-cell lymphoma: A clinicopathologic study of 42 cases. J Clin Oncol 1984; 2: 788-94.
4. Coiffier B, Brousse N, Peuchmaur M et al. Peripheral T-cell lymphomas have a worse prognosis than B-cell lymphomas: A prospective study of 361 immunophenotyped patients treated with LNH84 regimen. Ann Oncol 1990; 1: 45-50.
5. Melnyk A, Rodríguez A, Pugh WC, Cabanillas F. Evaluation of the revised European-American lymphoma classification confirms the clinical relevance of immonophenotype in 560 cases of aggressive non-Hodgkin's lymphoma. Blood 1997; 89: 4514-20.
6. The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group Classification of non-Hodgkin's lymphoma. Blood 1997; 89: 3909-18.
7. Ascani S, Zinzani PL, Gherlinzoni F et al. Peripheral T-cell lymphomas. Clinico-pathologic study of 168 cases diagnosed according to the R.E.A.L. Classification. Ann Oncol 1997; 8: 583-92.
8. Su IJ, Wang CH, Cheng AL et al. Characterization of the spectrum of postthymic T-cell malignancies in Taiwan. A clinicopathologic study of HTLVI-positive and HTLVI-negative cases. Cancer 1988; 61: 2060-70.
9. Takagi N, Nakamura S, Ueda R et al. A phenotypic and genotypic study of three node-based, low-grade peripheral T-cell lymphomas: Angioimmunoblastic lymphoma, T-zone lymphoma, and lymphoepithelioid lymphoma. Cancer 1992; 69: 2571-82.
10. Nakamura S, Suchi T, Koshikaua T et al. Clinicopathologic study of 212 cases of peripheral T-cell lymphoma among the Japanese. Cancer 1993; 72: 1762 72.
11. Siegert W, Agthe A, Grosser H et al. Tretament of angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma using prednisone with or without the COPBLAM/IMVP-16 regimen. A multicentre study. Ann Intern Med 1992; 117: 364-70.
12. Siegert W, Nerl C, Agthe A et al. Angioimmunoblastic lymphadenopathy (AILD)-type T-cell lymphoma: Prognostic impact of clinical observations and laboratory findings at presentation. Ann Oncol 1995; 6: 659-64.
13. Liang R, Todd D, Chan TK et al. Treatment outcome and prognostic factors for primary nasal lymphoma. J Clin Oncol 1995; 13: 666-70.
14. Macon WR, Williams ME, Greer JP et al. Natural killer-like T-cell lymphomas: Aggressive lymphomas of T-large granular lymphocytes. Blood 1996; 87: 1474-83.
15. Zinzani PL, Bendandi M, Martelli et al. Anaplastic large-cell lymphoma: Clinical and prognostic evaluation of 90 adult patients. J Clin Oncol 1996; 14: 955-62.
16. Tilly H, Gaulard P, Lepage E et al. Primary anaplastic large-cell lymphoma in adults: clinical presentation, immunophenotype, and outcome. Blood 1997; 90: 3727-34.
17. Sallah S, Smith SV, Lony LC et al. Gamma/delta T-cell hepatosplenic lymphoma: Review of the literature, diagnosis by flow cytometry and concomitant autoimmune hemolytic anemia. Ann Haematol 1997; 74: 139-42.
18. Isaacson P, Spencer J, Connolly C et al. Malignant histiocytosis of the intestine: A T-cell lymphoma. Lancet 1985; 2: 688-90.
19. Kwong YL, Chan AC, Liang R et al. CD56+ NK lymphomas: Clinicopathological features and prognosis. Br J Haematol 1997; 97: 821-9.
20. Kwak LW, Wilson M, Weiss LM et al. Similar outcome of treatment of B-cell and T-cell diffuse large-cell lymphomas: The Stanford experience. J Clin Oncol 1991; 9: 1426-31.
21. Armitage JO, Greer JP, Levine A et al. Peripheral T-cell lymphoma. Cancer 1989; 63: 158-63.
22. Lippman SM, Miller TP, Spier CM et al. The prognostic significance of the immunotype in diffuse large-cell lymphoma: A comparative study of the T-cell and B-cell phenotype. Blood 1988; 72: 436-41.
23. Cheng AL, Chen YC, Wang CH et al. Direct comparisons of peripheral T-cell lymphoma with diffuse B-cell lymphoma of comparable histological grades should peripheral T-cell lymphoma be considered separately? J Clin Oncol 1989; 7: 725-31.
24. Gisselbrecht C, Gaulard P, Lepage E et al. Prognostic significance of T-cell phenotype in aggressive non-Hodgkin's lymphoma. Blood 1998 (in press).
25. Karakas T, Bergmann L, Stutte HJ et al. Peripheral T-cell lymphomas respond well to vincristine, adriamycin, cyclophosphamide, prednisone and etoposide (VACPE) and have similar outcome as high-grade B-cell lymphomas. Leuk Lymph 1996; 24: 121-9.
26. Coiffier B, Shipp M, Cabanillas F et al. Report of the first workshop on prognostic factors in large-cell lymphomas. Ann Oncol 1991; 2 (Suppl 2): 213-7.
27. Shipp M. Prognostic factors in non-Hodgkin's lymphoma. Curr Opin Oncol 1992; 4: 856-62.
28. López-Guillermo A, Montserrat E, Reverter JC et al. Large-cell lymphoma: A study of prognostic factors and assessment of five recently proposed predictive systems. Leuk Lymph 1993; 10: 101-9.
29. The non-Hodgkin's lymphoma prognostic factors project. Development of a predictive model for aggressive lymphoma: The international NHL prognostic factors project. N Engl J Med 1993; 329: 987-94.
30. Montalbán C, Obeso G, Gallego A et al. Peripheral T-cell lymphoma: A clinicopathological study of 41 cases and evaluation of the prognostic significance of the Updated Kiel Classification. Histopathology 1993; 22: 303-10.
31. Kaplan EL, Meier P. Non-parametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457-81.
32. 2/E in the log-rank test for survival data or tumour incidence data. Biometrics 1973; 29: 759-84.
33. Cox DR. Regression models and life tables. J Royal Stat Soc 1972; 34: 187-220.
34. Lamant L, Meggetto F. al Saati T et al. High incidence of the t(2;5)(p23;q35) translocation in anaplastic large-cell lymphoma and its lack of detection in Hodgkin's disease. Comparison of cytogenetic analysis reverse transcriptase-polymerase chain reaction, and P-80 immunostaining. Blood 1996; 87: 284-91.
35. Yee HT, Ponzoni M, Merson A et al. Molecular characterization of the t(2;5)(p23:q35) translocation in anaplastic large-cell lymphoma (Ki-1) and Hodgkin's disease. Blood 1996; 87: 1081-8.
36. Pittaluga S, Bijnens L, Teodorovic I et al. Clinical analysis of 670 cases in two trials of the European Organozation for Research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European American Classification of lymphoid neoplasms: A comparison with the Working Formulation. Blood 1996; 87: 4358-67.
37. Ansell SM, Habermann TM, Kurtin PJ et al. Predictive capacity of the International Prognostic Factor Index in patients with peripheral T-cell lymphoma. J Clin Oncol 1997; 15: 2296-301.
38. Rodríguez J, Cabanillas F, McLauglin P et al. A proposal for a simple staging system for intermediate grade lymphoma and immunoblastic lymphoma based on the 'tumor score'. Ann Oncol 1992; 3: 711-7.